PLC cleaves the
phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) into
diacyl glycerol (DAG) and
inositol 1,4,5-trisphosphate (IP3). Thus PLC has a profound impact on the depletion of PIP2, which acts as a membrane anchor or allosteric regulator and an agonist for many
lipid-gated ion channels. PIP2 also acts as the substrate for synthesis of the rarer lipid
phosphatidylinositol 3,4,5-trisphosphate (PIP3), which is responsible for signaling in multiple reactions. Therefore, PIP2 depletion by the PLC reaction is critical to the regulation of local PIP3 concentrations both in the plasma membrane and the nuclear membrane. The two products of the PLC catalyzed reaction, DAG and IP3, are important second messengers that control diverse cellular processes and are substrates for synthesis of other important signaling molecules. When PIP2 is cleaved, DAG remains bound to the membrane, and IP3 is released as a soluble structure into the
cytosol. IP3 then diffuses through the cytosol to bind to
IP3 receptors, particularly
calcium channels in the
smooth endoplasmic reticulum (ER). This causes the cytosolic concentration of calcium to increase, causing a cascade of intracellular changes and activity. Both DAG and IP3 are substrates for the synthesis of regulatory molecules. DAG is the substrate for the synthesis of
phosphatidic acid, a regulatory molecule. IP3 is the rate-limiting substrate for the synthesis of inositol polyphosphates, which stimulate multiple protein kinases, transcription, and mRNA processing. Regulation of PLC activity is thus vital to the coordination and regulation of other enzymes of pathways that are central to the control of cellular physiology. Additionally, phospholipase C plays an important role in the inflammation pathway. The binding of agonists such as
thrombin,
epinephrine, or
collagen, to
platelet surface receptors can trigger the activation of phospholipase C to catalyze the release of
arachidonic acid from two major membrane phospholipids,
phosphatidylinositol and
phosphatidylcholine. Arachidonic acid can then go on into the cyclooxygenase pathway (producing
prostoglandins (PGE1, PGE2, PGF2),
prostacyclins (PGI2), or
thromboxanes (TXA2)), and the lipoxygenase pathway (producing
leukotrienes (LTB4, LTC4, LTD4, LTE4)). The bacterial variant
Clostridium perfringens type A produces alpha-toxin. The toxin has phospholipase C activity, and causes
hemolysis, lethality, and dermonecrosis. At high concentrations, alpha-toxin induces massive degradation of
phosphatidylcholine and
sphingomyelin, producing diacylglycerol and
ceramide, respectively. These molecules then participate in signal transduction pathways. The toxin-induced contraction was related to generation of thromboxane A2 from arachidonic acid. Thus it is likely the bacterial PLC mimics the actions of endogenous PLC in eukaryotic cell membranes. == See also ==